Ligand validation:5V2Y

AKG: 2-OXOGLUTARIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5V2Y_AKG_A_403	99%	17%	0.047	0.983	1.51	2.08	2	5	0	0	100%	1
5VKB_AKG_A_402	97%	22%	0.065	0.977	1.73	1.51	2	3	0	0	100%	1
6CBA_AKG_A_402	93%	23%	0.078	0.973	1.63	1.56	2	3	0	0	100%	0.92
5VKA_AKG_A_402	81%	17%	0.087	0.94	1.55	2.04	1	4	0	0	100%	0.89
5V2X_AKG_A_402	81%	28%	0.109	0.962	1.34	1.54	1	2	0	0	100%	0.36
6CF3_AKG_A_402	73%	26%	0.136	0.964	1.41	1.6	2	2	0	0	100%	0.63
4QKB_AKG_A_302	100%	20%	0.031	0.994	1.89	1.52	1	1	0	0	100%	1
3GR9_AKG_H_406	100%	10%	0.04	0.995	1.96	2.36	2	5	0	0	100%	1
8X6Q_AKG_D_403	100%	27%	0.041	0.985	1.35	1.58	1	4	0	0	100%	1
8X7C_AKG_B_402	100%	23%	0.041	0.981	1.26	1.92	1	5	0	0	100%	1
5Y9X_AKG_A_402	99%	29%	0.049	0.985	1.51	1.32	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.